Nevertheless, SGLT2-i have shown beneficial effects on arterial stiffness [151] and micro- and macrovascular endothelial function [152], which may give hope for the potential slowing of PAD progression in diabetic subjects. Here, SLC5A2 is linked to peripheral arterial disease.